Rene Levy
Affiliations: | Pharmaceutics | University of Washington, Seattle, Seattle, WA |
Website:
http://sop.washington.edu/levy-retires-almost-40-years/Google:
"Rene Levy"Mean distance: 3791.71
Children
Sign in to add trainee| Deanna L. Kroetz | grad student | 1990 | University of Washington |
| Colleen M. Wurden | grad student | 2000 | University of Washington |
| Caiping Yao | grad student | 2001 | University of Washington |
| Yun Xu | grad student | 2004 | University of Washington |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Levy R, Ragueneau-Majlessi I, Solanki B, et al. (2008) Pharmacokinetics, safety, and tolerability of the new antiepileptic carisbamate in the elderly. Epilepsy Research. 79: 22-30 |
| Levy RH, Hachad H, Yao C, et al. (2003) Relationship between extent of inhibition and inhibitor dose: literature evaluation based on the metabolism and transport drug interaction database. Current Drug Metabolism. 4: 371-80 |
| Yao C, Kunze KL, Trager WF, et al. (2003) Comparison of in vitro and in vivo inhibition potencies of fluvoxamine toward CYP2C19. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 31: 565-71 |
| Yao C, Levy RH. (2002) Inhibition-based metabolic drug-drug interactions: predictions from in vitro data. Journal of Pharmaceutical Sciences. 91: 1923-35 |
| Yao C, Kunze KL, Kharasch ED, et al. (2001) Fluvoxamine-theophylline interaction: gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2. Clinical Pharmacology and Therapeutics. 70: 415-24 |
| Spiegelstein O, Kroetz DL, Levy RH, et al. (2000) Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid. Pharmaceutical Research. 17: 216-21 |
| Yao CP, Mather GG, Stephens JR, et al. (1999) Cytotoxicity induced by the combination of valproic acid and tumor necrosis factor-alpha: implication for valproic acid-associated hepatotoxicity syndrome. Biochemical Pharmacology. 58: 455-9 |
| Kerr BM, Thummel KE, Wurden CJ, et al. (1994) Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochemical Pharmacology. 47: 1969-79 |
| Kroetz DL, Kerr BM, McFarland LV, et al. (1993) Measurement of in vivo microsomal epoxide hydrolase activity in white subjects. Clinical Pharmacology and Therapeutics. 53: 306-15 |
| Kroetz DL, Loiseau P, Guyot M, et al. (1993) In vivo and in vitro correlation of microsomal epoxide hydrolase inhibition by progabide. Clinical Pharmacology and Therapeutics. 54: 485-97 |